CRNA School Interview Pharmacology: Explain the Why

“So, how does norepinephrine work?” When you get CRNA school interview pharmacology questions like that one, explain what the drug does in a patient you’ve cared for, then name its mechanism, the effect you’d watch for, and one limitation. Start with the medications you use in your own ICU.

Updated October 2026.

If you work with vasopressors every week, you should be able to explain more than “it raises blood pressure.” And on the flip side, you don’t need to talk as if you’ve already practiced anesthesia (they know you haven’t, and that’s okay). The question is a chance to show how you think, straight from your nursing experience.

How do you answer CRNA school interview pharmacology questions?

Try this order: mechanism → expected effect → clinical context → what you would monitor. Say the answer in plain language first. Then add receptor names where they help explain the effect.

For example: “Norepinephrine has strong alpha-mediated vasoconstrictor activity and some beta-mediated inotropic activity. I’d expect vascular tone and blood pressure to rise. In septic shock, I’d also keep reassessing perfusion and the underlying cause of hypotension.” That’s SO much more useful than reciting an isolated drug card. The DailyMed norepinephrine label describes its alpha and beta actions, and the 2026 Surviving Sepsis guidelines recommend it as a first-line vasopressor for adult septic shock.

Keep a one-page card for each drug you actually use. Write its main mechanism, what you expect to change, one adverse effect to monitor, and a real situation where you cared about those effects. Then turn the card over and speak for 45 seconds. You want an explanation that survives a follow-up question, not a beautiful stack of notes. The CRNA interview question hub helps you mix drug questions with patient scenarios while you practice.

Which CRNA interview pharmacology questions should you practice out loud?

Cover the answer, talk for 30 to 60 seconds, then check yourself. Did you connect the drug to something happening at the bedside?

1. Why might norepinephrine raise blood pressure in septic shock?

Sepsis can reduce vascular tone. Norepinephrine’s alpha-adrenergic effect constricts blood vessels, which raises systemic vascular resistance and helps restore mean arterial pressure. Its beta-adrenergic activity might also stimulate cardiac contraction. I’d bring up perfusion, heart rate, rhythm, and the cause of shock too, because one blood pressure number isn’t the whole story. The 2026 sepsis guideline calls for repeated reassessment during resuscitation.

And please retire the old shortcut “norepinephrine must always run through a central line.” Current guidance suggests starting vasopressors peripherally in adult septic shock when waiting for central access would delay restoring pressure, with appropriate local safety practices in place.

Likely follow-up: “The MAP rose. Are you done?” No. You could say, “I would reassess mentation, urine output, skin perfusion, heart rate, and the broader trend. A pressure improvement doesn’t tell me the cause has been treated.” If they then ask how norepinephrine differs from fluid, explain that vasoconstriction and volume replacement address different problems. Don’t claim one automatically substitutes for the other in a patient you have not assessed.

2. What’s different about phenylephrine?

Phenylephrine acts mainly at alpha-1 receptors, so its direct effect is vasoconstriction. It doesn’t give you the same direct beta-mediated cardiac stimulation norepinephrine does. A rise in pressure might trigger reflex slowing of the heart rate, though you shouldn’t promise it happens in every patient. So start by explaining the receptor difference, then ask what the patient’s heart rate and cardiac output are doing. The DailyMed phenylephrine label describes its alpha-1 action.

Try saying it aloud: “Phenylephrine is primarily an alpha-1 agonist. I would expect vasoconstriction and a rise in pressure, but I would not assume cardiac output improves. I’d watch the heart rate and perfusion.” That’s the distinction to remember. If the panel asks which agent you would choose for a specific patient, ask for more clinical context instead of turning a receptor comparison into an unsupported prescription.

3. How would you explain propofol without calling it a GABA agonist?

Propofol is thought to produce sedation and anesthesia by positively modulating GABA’s inhibitory action at GABA-A receptors (practice saying “positively modulating” a few times, it’s a mouthful). Then move from the mechanism to the patient: depth of sedation, blood pressure, and breathing all matter. You might say, “I’d watch for hypotension and respiratory depression,” and then describe what you’ve actually monitored in your ICU. The wording on GABA comes from the DailyMed propofol label.

Follow-up question: “Your patient’s pressure drops after sedation starts. What would you check?” Start with the patient and the timing. Mention sedation depth, pressure trend, perfusion, other medications, and other causes of hypotension. If you answer “propofol causes hypotension” and stop, you’ve named one possible contributor without assessing what is happening. Stay within the experience you really have as an ICU nurse.

4. Why might dexmedetomidine affect heart rate and pressure?

Dexmedetomidine is an alpha-2 adrenergic agonist. Its sympatholytic action helps produce sedation, and bradycardia and hypotension are known adverse effects. If it’s a drug you’ve used, describe what you monitored and how your team responded when the vitals changed. Keep your answer tied to your own scope and experience. The DailyMed dexmedetomidine label covers its receptor action and hemodynamic effects.

Example answer: “Dexmedetomidine acts at alpha-2 receptors and reduces sympathetic activity. I pay attention to sedation, heart rate, and blood pressure. If the heart rate fell, I would assess the patient, the trend, and other contributors, then involve the team according to our unit process.” That is a much stronger answer than “it lowers the heart rate,” because it shows what you would do with the information.

5. How is vasopressin different from a catecholamine?

Vasopressin acts at vascular V1 receptors instead of adrenergic alpha or beta receptors. V1 activation contracts vascular smooth muscle. So in an interview, that difference gives you a reason to talk through why a team might add another pathway when pressure stays low on norepinephrine. The DailyMed vasopressin label describes V1 activity, and the 2026 sepsis guideline suggests adding vasopressin for adults with septic shock on escalating norepinephrine.

Follow-up question: “Is vasopressin the same as increasing norepinephrine?” No. Both may raise vascular tone, but they use different receptor pathways. I’d say what the team is trying to improve, then discuss perfusion and pressure trends instead of reciting a drip sequence. A two-sentence vignette leaves out the information needed to choose a medication for a real patient.

What does a useful drug study session look like before the interview?

Choose three drugs from your last few shifts. For each, have someone ask four questions: “How does it work?” “What do you expect to see?” “What would worry you?” and “What else could explain that change?” If you can answer the first three but freeze on the fourth, your weak spot is clinical context, not memorization. Review a patient you actually cared for, with all identifiers removed, and try again.

Then compare two drugs without making a treatment recommendation. Try, “How are norepinephrine and phenylephrine different?” You could answer, “Both constrict blood vessels, but norepinephrine has beta activity as well. I’d want to know the patient’s heart rate, cardiac function, perfusion, and cause of hypotension before discussing the clinical choice.” That is an interview answer you can defend. “One is better” is missing the patient.

Keep the comparison short enough that someone can follow it. If you spend a minute naming every receptor and never say what might happen to blood pressure, heart rate, or perfusion, pause and restart in bedside language. Then add only the receptor detail that explains the effect. That is the part you want to sound comfortable saying without a flashcard in your hand.

The CRNA Club Learning Library includes pharmacology review and drug charts for a more organized study pass. Pick the drug you stumbled over and use the lesson or chart to correct one specific gap. Then close it and answer the question aloud without notes. That second pass is where you find out whether you learned it.

What if the panel asks about a drug you rarely use?

Say what you know and mark the boundary out loud. Something like: “I haven’t administered that drug in my unit. I know its class, and I’d expect ___. I’d verify the specific dose and contraindications before using it.” Only fill in that blank if you actually know the class. An honest partial answer with a clear check beats a confident mistake, trust me.

Build a study sheet from your actual patient assignments. Which five drugs have you given or titrated lately? Pick those. For each one, write one sentence about the mechanism, one about the effect, one about a patient-specific concern, and one question you still need to research. That sheet sticks way better than an anesthesia formulary you’ve never touched (your future self studying for the boards will thank you).

For broader practice, use The CRNA Club’s interview question hub and clinical scenario questions. Then try a mock interview and listen for the moment your drug answer turns into a list of facts with no patient attached.